A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant...

A scientific paper released today in the Journal of Antibiotics presents the pre-clinical development of Ramizol®, a first generation drug belonging to a new class of styrylbenzene antibiotics with a...

A serious and sometimes fatal bacterial infection, known as methicillin-resistant Staphylococcus aureus (MRSA), may soon be beatable thanks to the efforts of University of South Florida scientists who...

Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced last week top-line results from the second Phase 3 study (RX-3341-303 NCT01984684)...

The U.S. Food and Drug Administration is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis,...

The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses: in combination with diet for the treatment of high triglycerides...

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) reported Friday on shortages of the antibiotic, Bicillin-LA (benzathine penicillin G). Benzathine penicillin...

A broad spectrum antibiotic that could become the first of its kind to treat specific Gram negative and Gram positive infections as well as tularemia, a bioterrorism threat, will undergo the last steps...

Impax Laboratories, Inc. announced earlier this week that EMVERM (mebendazole) 100 mg chewable tablets are now available for healthcare providers to prescribe to patients in the United States. EMVERM...

The Medicines Company today announced that the U.S. Food and Drug Administration ( FDA ) has granted Fast Track Designation to the investigational agent CARBAVANCE® (meropenem-vaborbactam) for the treatment...